Not Yet RecruitingNot Applicable

Fractional CO2 Laser Delivery of Topical Insulin Versus Platelet Rich Plasma in Treatment of Atrophic Post Acne Scars

22 participantsStarted 2024-11

Plain-language summary

compare the efficacy and safety of treating atrophic post acne scars with topical insulin versus Platelet rich Plasma PRP combined with fractional ablative Co2 laser

Who can participate

Age range18 Years – 65 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria: patients aged equal or more than 18 years with atrophic post acne scars. Exclusion criteria: pregnancy and lactation. Hypertrophic scars. patients suffering from aggressive inflammatory acne. kidney or liver disease. active infection at site of lesion. patients use medications that reduce tissue healing during the study.

What they're measuring

Efficacy and safety of treating atrophic post acne scars with topical insulin versus PRP combined with fractional ablative Co2 laser.

Timeframe: 5 months from the beginning of the treatment

Trial details

NCT IDNCT06590909

SponsorAssiut University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2027-06

Contact for this trial

Hager Gamal, mbBch

(+20)1007436862 hagermohamed21@gmail.com

View on ClinicalTrials.gov More Acne Vulgaris trials